Dallas campus researchers present study findings to FDA
Traditionally, compounded pharmaceuticals are quality checked through a “double-check”
system where a second pharmacist does a paper check to ensure that compounded pharmaceuticals
are prepared accurately. Unfortunately, the literature is replete with reports of
compounding errors related to the use of the double-check method of quality control.
With that in mind, a team of researchers from the Texas Tech University Health Sciences
Center (TTUHSC) School of Pharmacy, Cook Children’s Health Care System in Fort Worth and Children’s Medical Center in Dallas have been working to improve this practice that is so common to compounding
and reduce the number of compounding errors.
The researchers proposed a novel approach to assuring the quality of compounded pharmaceuticals through the use of hand-held Raman spectrometers. The results of their project, titled “Raman Spectroscopy: A Sensitive and Specific Technique for Determining the Accuracy of Compounded Pharmaceutical Formulations,” was recently published in the Journal of Pediatric Pharmacology and Therapeutics (21:413-8, 2016).
Because the study findings drew the attention of the U.S. Food and Drug Administration (FDA), School of Pharmacy researchers Claudia Meek, Ph.D., Trey Putnam, Ph.D., and Richard Leff, Pharm.D., were invited to speak about the study and its findings Dec. 15 at the FDA headquarters in Silver Springs, Maryland. More than 50 FDA officials — including several FDA directors — were invited to attend the presentation, which was part of FDA’s Critical Path Innovation Meetings.
Putnam said these preliminary studies demonstrated that the novel technique provided “robust quantitative information on the identity and the concentration of the formulation’s components.” In conclusion, he added, the investigators found that utilizing hand-held Raman spectrometers as a quality control measure is accurate, quantitative, rapid and cost-effective.
“The dialogue during the meeting was robust,” Putnam said. “FDA is interested in watching the future directions of our research.”
Related Stories
How Does Your Garden Grow?
As spring approaches, some people’s thoughts turn to gardening. Whether it’s a flower garden they desire or a vegetable garden want to have, they begin planning what they’ll plant and what they need to do to ensure a successful garden.
Adopt a Growth Mindset for a Better Life
A “growth mindset” accepts that our intelligence and talents can develop over time, and a person with that mindset understands that intelligence and talents can improve through effort and learning.
Drug Use, Family History Can Lead to Heart Disease in Younger Adults
Abstaining from drug abuse and an early diagnosis of familial hypercholesterolemia (high cholesterol) can help prevent heart disease.
Recent Stories
TTUHSC’s Castro-Quirino Named to 2023-24 Fellows of HACU’s Leadership Academy/La Academia de Liderazgo
HACU announced Sonya Castro-Quirino, D.Bioethics, TTUHSC vice president of Office of Institutional Compliance, as one of the 50 fellows of HACU’s Leadership Academy/La Academia de Liderazgo.
Ronald L. Cook, DO, MBA, named Texas Family Physician of the Year
Ronald L. Cook, DO, MBA, of Lubbock, Texas, was named the 2023 Texas Family Physician of the Year during TAFP’s Annual Session and Primary Care Summit in Grapevine on Nov. 11.
TTUHSC’s La-Beck to Use NIH Grant to Study Cancer Drug Delivery Via Nanoparticles
Ninh (Irene) La-Beck, Pharm.D., with the TTUHSC Jerry H. Hodge School of Pharmacy, received a five-year, $2.49 million grant to investigate how nanoparticles interact with the immune system and cancer.